Novel therapy
AssigneeLinnane Pharma AB
InventorsCatharina SVANBORG, Caterina CAFARO
Life of this patent
Estimating the term…
Abstract
A therapeutic agent comprising a bacteria which expresses an inhibitor of MYC activity or a extract or product obtainable therefrom, for use in for use in the prevention or treatment o disease wherein MYC levels are elevated, such as cancer. Inhibitors of MYC activity comprising a factor obtainable from bacteria are novel and form a further aspect of the invention.
Claims24
A pharmaceutical composition comprising a bacteria which expresses an inhibitor of MYC activity or a extract or product obtainable therefrom, and at least one pharmaceutically acceptable carrier.
8-9. (canceled)
A pharmaceutical composition comprising an inhibitor of MYC activity comprising a factor obtainable from a bacteria, and at least one pharmaceutically acceptable carrier.
(canceled)
Dependencies are inferred from the claim text.